Two growth stocks I think possess exciting potential are Experian (LSE: EXPN) and CVS Group (LSE: CVSG). Here’s why I plan to snap up some shares as soon as I have some available capital.
Experian
You may think of Experian as one of the largest credit score checking services, which is correct. However, there’s much more to the business and this is where the growth potential really excites me.
The shares are up 13% over a 12-month period, climbing from 2,825p at this time last year, to current levels of 3,235p.
In the digital world we live in, data is arguably one of the most coveted commodities and Experian has access to bucket loads of it! Credit scoring is already a great tool it offers and has helped the firm grow massively. With the AI revolution ramping up, the firm potentially has endless products and services it could provide with the data it possesses, which could boost share price, performance, and payouts.
To date, Experian’s excellent market share and growth has helped it perform well and record excellent organic growth. Plus, at present, there’s a dividend yield of 1.3% on offer. This isn’t the highest but could grow, in line with the business. However, dividends are never guaranteed.
From a bearish perspective, Experian shares trade for a premium on a price-to-earnings ratio of 30. Any bad news could send the shares tumbling. Conversely, I’m of the belief that sometimes you must pay a premium for quality companies. Furthermore, a bigger worry is the firm’s debt levels, standing close to £3.5bn. Paying down debt during times of higher interest can be costlier, and could take priority over growth aspirations.
So yes, I could wait for the shares to dip, but I don’t think they will. Barring a major issue, the only way is up for Experian shares, in my opinion.
CVS Group
CVS is a veterinary service provider to help us look after our pets. The business is split into four divisions, veterinary practices, laboratories, crematoria, and online retail.
The shares are down 16% over a 12-month period, from 1,918p at this point last year, to 1,685p as I write.
CVS’s growth potential is sky high, if you ask me. Firstly, pet ownership has never been higher than now, at least in the UK. Our pets need the same love, attention, and amenities that we do! That leads me nicely onto my next point, which is CVS’s multi faceted offering. This ranges from general healthcare, unfortunate but essential funeral services, as well as retail for owners to buy essentials and spoil their pets!
The company’s organic and acquisition-led journey has been impressive to date. However, the latter is something I do consider risky. When acquisitions don’t work out, they can be costly financially, as well as have lasting damage to investor sentiment and potentially returns too.
Its half year update released yesterday was positive. For the six months ended 31 December 2023, four new acquisitions were completed in Australia as the company broadened its footprint. Revenue and like-for-like sales increased by 11% and 6%. Furthermore, membership numbers increased too.
CVS looks well positioned to benefit from rising pet ownership numbers and there’s no telling where the shares could go, especially when volatility dissipates.
The post 2 exciting growth stocks that could fly high! appeared first on The Motley Fool UK.
Should you buy Cvs Group Plc shares today?
Before you decide, please take a moment to review this first.
Because my colleague Mark Rogers – The Motley Fool UK’s Director of Investing – has released this special report.
It’s called ‘5 Stocks for Trying to Build Wealth After 50’.
And it’s yours, free.
Of course, the decade ahead looks hazardous. What with inflation recently hitting 40-year highs, a ‘cost of living crisis’ and threat of a new Cold War, knowing where to invest has never been trickier.
And yet, despite the UK stock market recently hitting a new all-time high, Mark and his team think many shares still trade at a substantial discount, offering savvy investors plenty of potential opportunities to strike.
That’s why now could be an ideal time to secure this valuable investment research.
Mark’s ‘Foolish’ analysts have scoured the markets low and high.
This special report reveals 5 of his favourite long-term ‘Buys’.
Please, don’t make any big decisions before seeing them.
Claim your free copy now
setButtonColorDefaults(“#5FA85D”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43A24A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#FFFFFF”, ‘color’, ‘#FFFFFF’);
})()
More reading
3 FTSE 100 growth stocks I’d buy for an empty ISA in a heartbeat
UK stock investing: 1 of the top growth stocks to buy now?
Investing £100 a month? I’m considering this growing FTSE 100 company
Will the Experian share price beat the FTSE 100 again in 2024?
A once-in-a-decade chance to buy these brilliant FTSE stocks at bargain prices?
Sumayya Mansoor has no position in any of the shares mentioned. The Motley Fool UK has recommended Experian Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.